These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31425765)

  • 1. Superbugs but no drugs: steps in averting a post-antibiotic era.
    Hamad M; Al-Marzooq F; Orive G; Al-Tel TH
    Drug Discov Today; 2019 Dec; 24(12):2225-2228. PubMed ID: 31425765
    [No Abstract]   [Full Text] [Related]  

  • 2. The race for antimicrobials in the multidrug resistance era.
    Molina-Santiago C; de Vicente A; Romero D
    Microb Biotechnol; 2018 Nov; 11(6):976-978. PubMed ID: 29205906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction.
    Collatz E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():1. PubMed ID: 19040460
    [No Abstract]   [Full Text] [Related]  

  • 4. Multi-resistant bacteria--recent trends in emerging zoonotic agents.
    Kreienbrock L; Wieler LH
    Berl Munch Tierarztl Wochenschr; 2014; 127(9-10):337-8. PubMed ID: 25868160
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiresistant pathogens in cystic fibrosis].
    Cantón R; Girón R; Martínez-Martínez L; Oliver A; Solé A; Valdezate S; Máiz L
    Arch Bronconeumol; 2002 Aug; 38(8):376-85. PubMed ID: 12199920
    [No Abstract]   [Full Text] [Related]  

  • 6. When Humans Met Superbugs: Strategies to Tackle Bacterial Resistances to Antibiotics.
    Bravo A; Ruiz-Cruz S; Alkorta I; Espinosa M
    Biomol Concepts; 2018 Dec; 9(1):216-226. PubMed ID: 30811343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiresistance and 'superbugs'.
    Livermore D
    Commun Dis Public Health; 1998 Jun; 1(2):74-6. PubMed ID: 9644116
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential Treatment Options in a Post-antibiotic Era.
    Bragg RR; Meyburgh CM; Lee JY; Coetzee M
    Adv Exp Med Biol; 2018; 1052():51-61. PubMed ID: 29785480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small-molecule antibiotics pipeline: 2014-2018.
    Lepore C; Silver L; Theuretzbacher U; Thomas J; Visi D
    Nat Rev Drug Discov; 2019 Sep; 18(10):739. PubMed ID: 31570838
    [No Abstract]   [Full Text] [Related]  

  • 11. The Future of Antibiotics: Emerging Technologies and Stewardship.
    Fortman JL; Mukhopadhyay A
    Trends Microbiol; 2016 Jul; 24(7):515-517. PubMed ID: 27229181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial resistance: no action today, no cure tomorrow.
    Sharma A
    Indian J Med Microbiol; 2011; 29(2):91-2. PubMed ID: 21654100
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era.
    Baglioni P
    J Antimicrob Chemother; 2009 Apr; 63(4):846; author reply 846-7. PubMed ID: 19190101
    [No Abstract]   [Full Text] [Related]  

  • 15. New antibiotic agents in the pipeline and how they can help overcome microbial resistance.
    Gould IM; Bal AM
    Virulence; 2013 Feb; 4(2):185-91. PubMed ID: 23302792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
    Annunziato G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting antibiotic resistance.
    Martínez JL; Baquero F; Andersson DI
    Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Müller A
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S6-S7. PubMed ID: 30453362
    [No Abstract]   [Full Text] [Related]  

  • 20. Infections à bactéries multirésistantes, nouvelles molécules et bon usage antibiotique.
    Matt M; Bessis S
    Med Mal Infect; 2019; 49 Suppl 1():S6-S9. PubMed ID: 31542074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.